![]() |
![]() |
Monday, 11 October 2010 19:23 | |
CD8+ Cell anti-HIV Factor (CAF) Study Levy Lab University of California, San Francisco Department of Medicine Principal Investigator: Jay Levy, M.D.
Dr. Jay Levy 415-476-4071 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
Please Donate!
Please make a tax deductible donation to Zephyr LTNP Foundation, a 501(c)(3) entity via Paypal. No Paypal account required.
CROI 2011
|
Latest News
- Raffle Winners
- 09-06-2010: New Research Abstracts posted in Links
- 2/26/10 Science Daily: "Innate Mechanisms Can Control Disease Progression in HIV-Positive Patients", Barcelona, Spain research findings on dendritic cell
- 03/10/2010 Press Release: "Unraveling the Mystery Behind HIV/AIDS", Singapore Agency for Science, Technology and Research
- Extended Interview: Bruce Walker, Ragon Institute
Studies
- Leukapheresis Procedures to Study HIV-Specific Immunity [HIV+ Long-Term Non-Progressor (LTNP) Study]
- The Use of Leukapheresis to Support HIV Pathogenesis Studies
- The Host Genetics, Immunology and Virology of HIV Study (Formerly ‘International HIV Controller Study’)
- Elite Controller: A Study for HIV-Positive Persons Who Are Not On Meds
- Effects of HIV Infection on Mucosal Immunity in the Gut and Endometrium Study Effects of Menopause on the Immune Microenvironment of the Upper Reproductive Tract Study
- Effects of HIV Infection on Mucosal Immunity in the Gut and Endometrium Study
- Central Nervous System Biomarkers in HIV Controllers Study
- CCRC: Cell-Mediated Immune Responses to HIV-1 in Gut-associated Lymphoid Tissue (GALT) Study
- CD8+ Cell anti-HIV Factor (CAF) Study
- The Host Genetics, Immunology and Virology of HIV Study / Reproductive Tract Study
Controllers in Study



86%
Our Goal:
2000
Currently:
1725
Updated:
December 30, 2009
Current Breakdown: 505 Elite Controllers 1009 Viremic Controllers 211 Other